Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19

Coronavirus disease-2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the most concerning health problem worldwide. SARS-CoV-2 infects cells by binding to angiotensin-converting enzyme 2 (ACE2). It is believed that the differential response...

Descripción completa

Detalles Bibliográficos
Autores principales: Issa, Hawraa, Eid, Ali H., Berry, Bassam, Takhviji, Vahideh, Khosravi, Abbas, Mantash, Sarah, Nehme, Rawan, Hallal, Rawan, Karaki, Hussein, Dhayni, Kawthar, Faour, Wissam H., Kobeissy, Firas, Nehme, Ali, Zibara, Kazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012486/
https://www.ncbi.nlm.nih.gov/pubmed/33816521
http://dx.doi.org/10.3389/fmed.2021.620990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012486/
https://www.ncbi.nlm.nih.gov/pubmed/33816521
http://dx.doi.org/10.3389/fmed.2021.620990

Ejemplares similares